No Data
No Data
Zhejiang Gongdong Medical Technology (605369.SH): plans to spend 18-36 million yuan to repurchase shares.
Zhejiang Gongdong Medical Technology (605369.SH) announced that the company plans to use its own funds to repurchase some of its publicly traded shares for employee stock ownership plans or stock-based incentives. The amount of repurchased shares is not less than RMB 18 million (inclusive) and not more than RMB 36 million, and the repurchase price per share does not exceed RMB 42.34 (inclusive).
Zhejiang Gongdong Medical Technology (605369.SH): Its controlling shareholder Shi Huiyong has cumulatively reduced 3.1514 million shares of the company's stock.
On July 26th, GeLongHui reported that Zhejiang Gongdong Medical Technology (605369.SH) received a notice from Mr. Shi Huiyong regarding the results of shareholding reduction on July 26th, 2024. Mr. Shi Huiyong reduced his shares by a cumulative total of 3,151,400 shares through block trading, accounting for 1.9999% of the total share capital of the company. After this block trading, the shareholding plan has been completed. After the shareholding plan is completed, Mr. Shi Huiyong holds 79,168,600 shares of the company's stocks, accounting for 50.2408% of the total share capital.
Zhejiang Gongdong Medical Technology: Announcement of expected increase in performance for the first half of 2024.
We Wouldn't Be Too Quick To Buy Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369) Before It Goes Ex-Dividend
Zhejiang Gongdong Medical Technology (605369.SH) 2023 annual equity distribution: 0.30 yuan per share and 0.4 shares bonus. Registration of share rights on July 8th.
Zhejiang Gongdong Medical Technology Co., Ltd. (605369.SH) released an announcement on the implementation of annual equity distribution for 2023. Based on the total share capital of the company before the implementation of the plan, a cash dividend of 0.3 yuan per share (including tax) will be distributed to all shareholders by transferring 0.4 shares from the capital reserve fund. The record date for the shareholders is July 8, 2024, and the ex-right (ex-dividend) date is July 9, 2024.
Zhejiang Gongdong Medical Technology (605369.SH): The controlling shareholder Shi Huiyong plans to reduce his holdings by no more than 2% through a bulk trade.
Zhejiang Gongdong Medical Technology (605369.SH) announced that the controlling shareholder Shi Huiyong planned to reduce the company's holdings by no more than 2,252,300 shares through block trading within 3 months after 15 trading days from the date of this announcement, and the total number of shares sold during any consecutive 90-day period shall not exceed 2% of the company's total share capital. The sale price will be determined based on the market price at the time of the sale.
No Data